Brinkley Ruth Williams 4
4 · Travere Therapeutics, Inc. · Filed Sep 16, 2021
Insider Transaction Report
Form 4
Williams Brinkley Ruth
Director
Transactions
- Award
Common Stock
2021-09-14+5,250→ 5,250 total - Award
Stock Option (Right to Buy)
2021-09-14+15,750→ 15,750 totalExercise: $23.61Exp: 2031-09-13→ Common Stock (15,750 underlying)
Footnotes (1)
- [F1]One-third of the shares subject to the stock option vest and become exercisable on the first anniversary of the date of grant, and the remaining shares vest in 24 equal monthly installments thereafter.